Perspective Therapeutics Inc (CATX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Sales | 337 | 276 | 588 | 233 | 0 |
| Gross Profit | 337 | 276 | 588 | 233 | N/A |
| Operating Expenses | 12,013 | 10,026 | 10,342 | 9,994 | 0 |
| Operating Income | -11,676 | -9,750 | -9,754 | -9,761 | N/A |
| Interest Expense | 24 | 14 | 26 | 18 | 0 |
| Other Income | 57 | 192 | 294 | 374 | 0 |
| Pre-tax Income | -11,643 | -9,572 | -9,486 | -9,405 | 0 |
| Income Tax | N/A | N/A | N/A | -10,500 | N/A |
| Net Income Continuous | -22,143 | -9,572 | -9,486 | 1,095 | N/A |
| Net Income Discontinuous | -5,183 | -784 | -1,620 | -1,466 | N/A |
| Net Income | $-24,675 | $-10,356 | $-11,106 | $-371 | $N/A |
| EPS Basic Total Ops | -0.97 | -0.37 | -0.40 | 0.00 | N/A |
| EPS Basic Continuous Ops | -0.82 | -0.34 | -0.34 | 0.10 | N/A |
| EPS Basic Discontinuous Ops | -0.15 | -0.03 | -0.06 | -0.10 | N/A |
| EPS Diluted Total Ops | -0.97 | -0.37 | -0.40 | 0.00 | N/A |
| EPS Diluted Continuous Ops | -0.82 | -0.34 | -0.34 | 0.10 | N/A |
| EPS Diluted Discontinuous Ops | -0.15 | -0.03 | -0.06 | -0.10 | N/A |
| EBITDA(a) | $-11,430 | $-9,452 | $-9,501 | $-9,572 | $N/A |